GEA
Glen Eagle Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.69M | Sell |
20,370
-515
| -2% | -$42.7K | 0.26% | 72 |
|
|
2025
Q1 | $1.69M | Buy |
20,885
+55
| +0.3% | +$4.46K | 0.28% | 65 |
|
|
2024
Q4 | $1.88M | Buy |
20,830
+1,654
| +9% | +$149K | 0.31% | 63 |
|
|
2024
Q3 | $1.89M | Sell |
19,176
-347
| -2% | -$34.3K | 0.32% | 64 |
|
|
2024
Q2 | $1.81M | Buy |
19,523
+120
| +0.6% | +$11.1K | 0.33% | 62 |
|
|
2024
Q1 | $1.84M | Buy |
19,403
+340
| +2% | +$32.3K | 0.35% | 61 |
|
|
2023
Q4 | $1.7M | Buy |
19,063
+680
| +4% | +$60.7K | 0.35% | 58 |
|
|
2023
Q3 | $1.34M | Buy |
18,383
+118
| +0.6% | +$8.62K | 0.31% | 69 |
|
|
2023
Q2 | $1.52M | Buy |
18,265
+2,417
| +15% | +$201K | 0.35% | 62 |
|
|
2023
Q1 | $1.21M | Sell |
15,848
-243
| -2% | -$18.5K | 0.3% | 71 |
|
|
2022
Q4 | $1.34M | Sell |
16,091
-1,275
| -7% | -$106K | 0.36% | 59 |
|
|
2022
Q3 | $1.38M | Sell |
17,366
-344
| -2% | -$27.3K | 0.4% | 57 |
|
|
2022
Q2 | $1.32M | Sell |
17,710
-1,115
| -6% | -$82.8K | 0.36% | 62 |
|
|
2022
Q1 | $1.69M | Buy |
18,825
+55
| +0.3% | +$4.94K | 0.44% | 52 |
|
|
2021
Q4 | $2.1M | Buy |
18,770
+226
| +1% | +$25.3K | 0.55% | 42 |
|
|
2021
Q3 | $2.33M | Buy |
18,544
+433
| +2% | +$54.4K | 0.67% | 35 |
|
|
2021
Q2 | $2.45M | Buy |
18,111
+395
| +2% | +$53.5K | 0.76% | 30 |
|
|
2021
Q1 | $2.4M | Buy |
17,716
+495
| +3% | +$67.1K | 0.84% | 27 |
|
|
2020
Q4 | $2.42M | Buy |
17,221
+45
| +0.3% | +$6.34K | 0.95% | 21 |
|
|
2020
Q3 | $1.91M | Buy |
17,176
+180
| +1% | +$20.1K | 0.86% | 28 |
|
|
2020
Q2 | $1.9M | Buy |
16,996
+320
| +2% | +$35.8K | 0.98% | 22 |
|
|
2020
Q1 | $1.29M | Sell |
16,676
-145
| -0.9% | -$11.2K | 0.91% | 28 |
|
|
2019
Q4 | $1.6M | Buy |
16,821
+1,862
| +12% | +$177K | 0.85% | 29 |
|
|
2019
Q3 | $1.14M | Sell |
14,959
-921
| -6% | -$70.2K | 0.75% | 31 |
|
|
2019
Q2 | $1.39M | Buy |
15,880
+252
| +2% | +$22.1K | 0.95% | 23 |
|
|
2019
Q1 | $1.41M | Sell |
15,628
-125
| -0.8% | -$11.3K | 1.03% | 20 |
|
|
2018
Q4 | $1.1M | Sell |
15,753
-1,385
| -8% | -$96.7K | 0.93% | 25 |
|
|
2018
Q3 | $1.64M | Buy |
17,138
+1,595
| +10% | +$153K | 1.17% | 20 |
|
|
2018
Q2 | $1.48M | Buy |
15,543
+875
| +6% | +$83.3K | 1.16% | 19 |
|
|
2018
Q1 | $1.29M | Buy |
14,668
+2,031
| +16% | +$178K | 1.06% | 22 |
|
|
2017
Q4 | $1.07M | Buy |
12,637
+2,161
| +21% | +$183K | 0.93% | 21 |
|
|
2017
Q3 | $907K | Sell |
10,476
-6,584
| -39% | -$570K | 0.85% | 28 |
|
|
2017
Q2 | $1.33M | Buy |
17,060
+670
| +4% | +$52.1K | 1.06% | 17 |
|
|
2017
Q1 | $1.14M | Buy |
16,390
+770
| +5% | +$53.3K | 0.98% | 19 |
|
|
2016
Q4 | $925K | Buy |
+15,620
| New | +$925K | 0.83% | 23 |
|